BIOMAT Database Logo BIOMAT Database Logo

Leukotriene D4 (LTD4) antagonists: structure activity relationships of stable phenylsubstituted leukotriene analogs. 1989

A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
Research Department, CIBA-GEIGY Ltd., Basel, Switzerland.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013189 SRS-A A group of LEUKOTRIENES; (LTC4; LTD4; and LTE4) that is the major mediator of BRONCHOCONSTRICTION; HYPERSENSITIVITY; and other allergic reactions. Earlier studies described a "slow-reacting substance of ANAPHYLAXIS" released from lung by cobra venom or after anaphylactic shock. The relationship between SRS-A leukotrienes was established by UV which showed the presence of the conjugated triene. (From Merck Index, 11th ed) Slow Reacting Substance of Anaphylaxis
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015289 Leukotrienes A family of biologically active compounds derived from arachidonic acid by oxidative metabolism through the 5-lipoxygenase pathway. They participate in host defense reactions and pathophysiological conditions such as immediate hypersensitivity and inflammation. They have potent actions on many essential organs and systems, including the cardiovascular, pulmonary, and central nervous system as well as the gastrointestinal tract and the immune system. Leukotriene
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
Development of a series of phenyltetrazole leukotriene D4 (LTD4) receptor antagonists.
April 1992, Journal of medicinal chemistry,
A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
[Leukotriene D4 antagonists].
April 2000, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
Novel leukotriene antagonists: structure activity of analogs of LTD4. Replacement of the 1-carboxylic group by a methyl group ("methyl principle") results in leukotriene antagonists and phospholipase inhibitors.
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
N-carbamoyl analogs of Zafirlukast: potent receptor antagonists of leukotriene D4.
September 1998, Bioorganic & medicinal chemistry letters,
A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
Chemistry and structure-activity relationships of leukotriene receptor antagonists
June 1998, American journal of respiratory and critical care medicine,
A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
Chemistry and structure--activity relationships of leukotriene receptor antagonists.
June 1998, American journal of respiratory and critical care medicine,
A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
Synthesis and LTD4-antagonist activity of desamino-2-nor-leukotriene analogs.
January 1985, Prostaglandins,
A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
Leukotriene D4 (LTD4)/leukotriene B4 (LTB4) interactions in the pathophysiology of experimental glomerulonephritis.
January 1989, Advances in prostaglandin, thromboxane, and leukotriene research,
A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.
April 1998, Journal of medicinal chemistry,
A von Sprecher, and W Breltenstein, and A Beck, and W Anderson, and M A Bray, and F Märkl
Effects of combined receptor antagonists of leukotriene D4 (LTD4) and platelet-activating factor (PAF) on rhesus airway responses to LTD4, PAF and antigen.
January 1989, International archives of allergy and applied immunology,
Copied contents to your clipboard!